DE
TEVA icon

DV Equities’s Teva Pharmaceuticals TEVA Stock Holding History

DV Equities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$68.7K Buy
+2,200
New +$54.2K 0.01% 295

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

DV Equities's TEVA Position: Q4 2025 in Review

DV Equities opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2025: 2,200 shares worth $68.7K. The stake represents 0.01% of the portfolio and ranks #295 among its holdings.

631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • DV Equities held 2,200 shares of Teva Pharmaceuticals worth $68.7K as of Q4 2025.
  • Teva Pharmaceuticals was a new DV Equities position in Q4 2025.
  • Teva Pharmaceuticals made up 0.01% of DV Equities's portfolio in Q4 2025, its #295 holding.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.